Inhibrx Biosciences, Inc. (INBX)
123.41
-0.52
(-0.42%)
USD |
NASDAQ |
Aug 28, 16:00
123.34
-0.07
(-0.06%)
Pre-Market: 20:00
Inhibrx Biosciences Price to Book Value
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| March 30, 2026 | 109.21 |
| March 27, 2026 | 106.49 |
| March 26, 2026 | 119.99 |
| March 25, 2026 | 121.21 |
| March 24, 2026 | 115.12 |
| March 23, 2026 | 117.87 |
| March 20, 2026 | 111.11 |
| March 19, 2026 | 118.31 |
| March 18, 2026 | 125.28 |
| March 17, 2026 | 127.14 |
| March 16, 2026 | 126.32 |
| March 13, 2026 | 125.37 |
| March 12, 2026 | 126.39 |
| March 11, 2026 | 134.05 |
| March 10, 2026 | 130.64 |
| March 09, 2026 | 131.06 |
| March 06, 2026 | 126.17 |
| March 05, 2026 | 128.87 |
| March 04, 2026 | 136.11 |
| March 03, 2026 | 135.56 |
| March 02, 2026 | 141.33 |
| February 27, 2026 | 135.20 |
| February 26, 2026 | 140.85 |
| February 25, 2026 | 146.40 |
| February 24, 2026 | 144.99 |
| Date | Value |
|---|---|
| February 23, 2026 | 139.68 |
| February 20, 2026 | 143.42 |
| February 19, 2026 | 147.87 |
| February 18, 2026 | 148.79 |
| February 17, 2026 | 143.66 |
| February 13, 2026 | 138.24 |
| February 12, 2026 | 149.75 |
| February 11, 2026 | 149.53 |
| February 10, 2026 | 151.92 |
| February 09, 2026 | 157.74 |
| February 06, 2026 | 153.03 |
| February 05, 2026 | 148.69 |
| February 04, 2026 | 150.57 |
| February 03, 2026 | 155.17 |
| February 02, 2026 | 149.97 |
| January 30, 2026 | 139.10 |
| January 29, 2026 | 132.33 |
| January 28, 2026 | 134.92 |
| January 27, 2026 | 134.03 |
| January 26, 2026 | 131.31 |
| January 23, 2026 | 136.16 |
| January 22, 2026 | 144.97 |
| January 21, 2026 | 136.97 |
| January 20, 2026 | 132.95 |
| January 16, 2026 | 131.81 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| AnaptysBio, Inc. | 128.17 |
| 4D Molecular Therapeutics, Inc. | 1.987 |
| Design Therapeutics, Inc. | 4.684 |
| Agenus, Inc. | -- |
| Amgen, Inc. | 20.00 |
Price to Book Value Related Metrics
| Price | 123.41 |
| Earnings Yield | -7.19% |
| Market Cap | 1.815B |